Table of Contents

June 2010, Volume 17, Number 2

Review

    • Elizabeth W LaPensee and
    • Nira Ben-Jonathan

    Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy

    Endocr Relat Cancer 17 (2) R91-R107, doi:10.1677/ERC-09-0253 first published on 13 January 2010
    • Mark H Greene,
    • Christian P Kratz,
    • Phuong L Mai,
    • Christine Mueller,
    • June A Peters,
    • Gennady Bratslavsky,
    • Alex Ling,
    • Peter M Choyke,
    • Ahalya Premkumar,
    • Janet Bracci,
    • Rissah J Watkins,
    • Mary Lou McMaster,
    • and Larissa A Korde

    Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype

    Endocr Relat Cancer 17 (2) R109-R121, doi:10.1677/ERC-09-0254 first published on 21 January 2010
    • Emma-Leena Alarmo and
    • Anne Kallioniemi

    Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?

    Endocr Relat Cancer 17 (2) R123-R139, doi:10.1677/ERC-09-0273 first published on 24 March 2010

Regular papers

    • Vladislava Paharkova-Vatchkova and
    • Kuk-Wha Lee

    Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties

    Endocr Relat Cancer 17 (2) 293-302, doi:10.1677/ERC-09-0106 first published on 21 January 2010
    • Yvonne Arvidsson,
    • Anders Bergström,
    • Linda Arvidsson,
    • Erik Kristiansson,
    • Håkan Ahlman,
    • and Ola Nilsson

    Hypoxia stimulates CXCR4 signalling in ileal carcinoids

    Endocr Relat Cancer 17 (2) 303-316, doi:10.1677/ERC-09-0085 first published on 13 January 2010
    • Iñigo Landa,
    • Cristina Montero-Conde,
    • Donatella Malanga,
    • Silvia De Gisi,
    • Guillermo Pita,
    • Luis-Javier Leandro-García,
    • Lucía Inglada-Pérez,
    • Rocío Letón,
    • Carmela De Marco,
    • Cristina Rodríguez-Antona,
    • Giuseppe Viglietto,
    • and Mercedes Robledo

    Allelic variant at −79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels

    Endocr Relat Cancer 17 (2) 317-328, doi:10.1677/ERC-09-0016 first published on 14 January 2010
    • Kari Hemminki,
    • Seyed Mohsen Mousavi,
    • Andreas Brandt,
    • Jianguang Ji,
    • and Jan Sundquist

    Histology-specific risks in testicular cancer in immigrants to Sweden

    Endocr Relat Cancer 17 (2) 329-334, doi:10.1677/ERC-09-0284 first published on 28 January 2010
    • Inga Mertens-Walker,
    • Christine Bolitho,
    • Robert C Baxter,
    • and Deborah J Marsh

    Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase Cδ

    Endocr Relat Cancer 17 (2) 335-349, doi:10.1677/ERC-09-0152 first published on 5 February 2010
    • Carolyn Algire,
    • Lilian Amrein,
    • Mahvash Zakikhani,
    • Lawrence Panasci,
    • and Michael Pollak

    Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

    Endocr Relat Cancer 17 (2) 351-360, doi:10.1677/ERC-09-0252 first published on 15 February 2010
    • Françoise Galland,
    • Ludovic Lacroix,
    • Patrick Saulnier,
    • Philippe Dessen,
    • Geri Meduri,
    • Michèle Bernier,
    • Stéphane Gaillard,
    • Jean Guibourdenche,
    • Thierry Fournier,
    • Danièle Evain-Brion,
    • Jean Michel Bidart,
    • and Philippe Chanson

    Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis

    Endocr Relat Cancer 17 (2) 361-371, doi:10.1677/ERC-10-0018 first published on 3 March 2010
    • Roberta Fusco,
    • Mario Galgani,
    • Claudio Procaccini,
    • Renato Franco,
    • Giuseppe Pirozzi,
    • Laura Fucci,
    • Paolo Laccetti,
    • and Giuseppe Matarese

    Cellular and molecular crosstalk between leptin receptor and estrogen receptor-α in breast cancer: molecular basis for a novel therapeutic setting

    Endocr Relat Cancer 17 (2) 373-382, doi:10.1677/ERC-09-0340 first published on 22 February 2010
    • Wei Li and
    • Kenneth B Ain

    Human sodium–iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells

    Endocr Relat Cancer 17 (2) 383-398, doi:10.1677/ERC-09-0156 first published on 3 March 2010
    • Carla S Verissimo,
    • Jan J Molenaar,
    • John Meerman,
    • Jordi Carreras Puigvert,
    • Fieke Lamers,
    • Jan Koster,
    • Erik H J Danen,
    • Bob van de Water,
    • Rogier Versteeg,
    • Carlos P Fitzsimons,
    • and Erno Vreugdenhil

    Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cells

    Endocr Relat Cancer 17 (2) 399-414, doi:10.1677/ERC-09-0301 first published on 3 March 2010
    • Kiyoshi Takagi,
    • Yasuhiro Miki,
    • Shuji Nagasaki,
    • Hisashi Hirakawa,
    • Yoshiaki Onodera,
    • Jun-ichi Akahira,
    • Takanori Ishida,
    • Mika Watanabe,
    • Izo Kimijima,
    • Shin-ichi Hayashi,
    • Hironobu Sasano,
    • and Takashi Suzuki

    Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment

    Endocr Relat Cancer 17 (2) 415-430, doi:10.1677/ERC-09-0257 first published on 3 March 2010
    • Xiao-Dong Fu,
    • Lorenzo Goglia,
    • Angel Matias Sanchez,
    • Marina Flamini,
    • Maria S Giretti,
    • Veronica Tosi,
    • Andrea R Genazzani,
    • and Tommaso Simoncini

    Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase

    Endocr Relat Cancer 17 (2) 431-443, doi:10.1677/ERC-09-0258 first published on 8 March 2010
    • Paola Sperone,
    • Anna Ferrero,
    • Fulvia Daffara,
    • Adriano Priola,
    • Barbara Zaggia,
    • Marco Volante,
    • Daniele Santini,
    • Bruno Vincenzi,
    • Giuseppe Badalamenti,
    • Chiara Intrivici,
    • Sabrina Del Buono,
    • Silvia De Francia,
    • Emmanouil Kalomirakis,
    • Riccardo Ratti,
    • Alberto Angeli,
    • Luigi Dogliotti,
    • Mauro Papotti,
    • Massimo Terzolo,
    • and Alfredo Berruti

    Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

    Endocr Relat Cancer 17 (2) 445-453, doi:10.1677/ERC-09-0281 first published on 18 March 2010
    • M Shiota,
    • Y Song,
    • A Yokomizo,
    • Y Tada,
    • K Kuroiwa,
    • M Eto,
    • Y Oda,
    • J Inokuchi,
    • T Uchiumi,
    • N Fujimoto,
    • N Seki,
    • and S Naito

    Human heterochromatin protein 1 isoform HP1β enhances androgen receptor activity and is implicated in prostate cancer growth

    Endocr Relat Cancer 17 (2) 455-467, doi:10.1677/ERC-09-0321 first published on 18 March 2010
    • Karin Jennbacken,
    • Tajana Tešan,
    • Wanzhong Wang,
    • Heléne Gustavsson,
    • Jan-Erik Damber,
    • and Karin Welén

    N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer

    Endocr Relat Cancer 17 (2) 469-479, doi:10.1677/ERC-10-0015 first published on 9 March 2010
    • Lei Gu,
    • Paraskevi Vogiatzi,
    • Martin Puhr,
    • Ayush Dagvadorj,
    • Jacqueline Lutz,
    • Amy Ryder,
    • Sankar Addya,
    • Paolo Fortina,
    • Carlton Cooper,
    • Benjamin Leiby,
    • Abhijit Dasgupta,
    • Terry Hyslop,
    • Lukas Bubendorf,
    • Kalle Alanen,
    • Tuomas Mirtti,
    • and Marja T Nevalainen

    Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

    Endocr Relat Cancer 17 (2) 481-493, doi:10.1677/ERC-09-0328 first published on 10 March 2010
    • Chiara Laezza,
    • Anna Maria Malfitano,
    • Maria Chiara Proto,
    • Iolanda Esposito,
    • Patrizia Gazzerro,
    • Pietro Formisano,
    • Simona Pisanti,
    • Antonietta Santoro,
    • Maria Gabriella Caruso,
    • and Maurizio Bifulco

    Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells

    Endocr Relat Cancer 17 (2) 495-503, doi:10.1677/ERC-10-0009 first published on 19 March 2010
    • Zhigang Zhao and
    • Guohua Zeng

    Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in men with high-grade prostatic intraepithelial neoplasia

    Endocr Relat Cancer 17 (2) 505-512, doi:10.1677/ERC-10-0017 first published on 22 March 2010
    • Leelamma M Panicker,
    • Jian-Hua Zhang,
    • Pradeep K Dagur,
    • Matthew J Gastinger,
    • and William F Simonds

    Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism–jaw tumor syndrome

    Endocr Relat Cancer 17 (2) 513-524, doi:10.1677/ERC-09-0272 first published on 19 March 2010
    • Martin Puhr,
    • Frédéric R Santer,
    • Hannes Neuwirt,
    • Gemma Marcias,
    • Alfred Hobisch,
    • and Zoran Culig

    SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling

    Endocr Relat Cancer 17 (2) 525-538, doi:10.1677/ERC-10-0007 first published on 24 March 2010
    • L Zeng,
    • K M Biernacka,
    • J M P Holly,
    • C Jarrett,
    • A A Morrison,
    • A Morgan,
    • Z E Winters,
    • E J Foulstone,
    • J P Shield,
    • and C M Perks

    Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase

    Endocr Relat Cancer 17 (2) 539-551, doi:10.1677/ERC-09-0221 first published on 31 March 2010

Erratum

|

This Issue

June 2010; 17 (2)
Cover
  1. Review
  2. Regular papers
  3. Erratum

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most